Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Daymark Wealth Partners LLC

Daymark Wealth Partners LLC lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 6,529 shares of the medical equipment provider’s stock after selling 498 shares during the quarter. Daymark Wealth Partners LLC’s holdings in Intuitive Surgical were worth $3,408,000 as of its most recent filing with the SEC.

A number of other large investors also recently added to or reduced their stakes in the stock. State Street Corp grew its holdings in shares of Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after purchasing an additional 210,363 shares during the period. FMR LLC boosted its holdings in Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after purchasing an additional 838,793 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Intuitive Surgical by 1.9% during the 3rd quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock worth $3,677,194,000 after buying an additional 143,440 shares during the last quarter. Fisher Asset Management LLC increased its stake in Intuitive Surgical by 1.8% during the third quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock worth $2,349,441,000 after acquiring an additional 86,208 shares during the last quarter. Finally, Baillie Gifford & Co. boosted its stake in Intuitive Surgical by 0.6% during the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock worth $1,890,676,000 after buying an additional 24,183 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

ISRG has been the topic of several research reports. JPMorgan Chase & Co. increased their target price on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Stifel Nicolaus boosted their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. Citigroup boosted their target price on shares of Intuitive Surgical from $567.00 to $640.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. Finally, Robert W. Baird raised their price target on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $554.17.

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 270 shares of the company’s stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total value of $145,840.50. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,730,093.55. This represents a 2.99 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Robert Desantis sold 1,012 shares of the firm’s stock in a transaction that occurred on Friday, October 25th. The stock was sold at an average price of $514.00, for a total transaction of $520,168.00. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,830,084. The trade was a 15.53 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 43,509 shares of company stock valued at $22,602,212 over the last quarter. Company insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Up 1.9 %

ISRG stock opened at $604.12 on Wednesday. The stock’s fifty day simple moving average is $543.14 and its 200-day simple moving average is $501.89. Intuitive Surgical, Inc. has a 52-week low of $362.14 and a 52-week high of $606.27. The stock has a market capitalization of $215.17 billion, a price-to-earnings ratio of 97.13, a price-to-earnings-growth ratio of 5.04 and a beta of 1.39.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.